[HTML][HTML] The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections

RJ Hsu, WC Yu, GR Peng, CH Ye, SY Hu… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in countless
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …

Advances in nanomaterial-based platforms to combat COVID-19: Diagnostics, preventions, therapeutics, and vaccine developments

N Mahmud, MI Anik, MK Hossain, MI Khan… - ACS Applied Bio …, 2022 - ACS Publications
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …

2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2

MA Unal, F Bayrakdar, L Fusco, O Besbinar, CE Shuck… - Nano Today, 2021 - Elsevier
Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly
growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model …

Current evidence on the use of anakinra in COVID-19

E Khani, M Shahrabi, H Rezaei, F Pourkarim… - International …, 2022 - Elsevier
Despite the progressing knowledge in COVID-19 management, remdesivir is the only agent
that got approval to inhibit viral replication. However, there are limited data about effective …

[HTML][HTML] Immune responses in mildly versus critically ill COVID-19 patients

H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …

[HTML][HTML] Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

YC Hwang, RM Lu, SC Su, PY Chiang, SH Ko… - Journal of Biomedical …, 2022 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public
health crisis that demands the timely creation of new therapeutics and viral detection. Owing …

[HTML][HTML] Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies

HF Rosenberg, PS Foster - Seminars in immunopathology, 2021 - Springer
The unprecedented impact of the coronavirus disease 2019 (COVID-19) pandemic has
resulted in global challenges to our health-care systems and our economic security. As …

[HTML][HTML] Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity

S Hazan, N Stollman, HS Bozkurt… - BMJ open …, 2022 - bmjopengastro.bmj.com
Objective The study objective was to compare gut microbiome diversity and composition in
SARS-CoV-2 PCR-positive patients whose symptoms ranged from asymptomatic to severe …

[HTML][HTML] CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses

S Jalloh, J Olejnik, J Berrigan, A Nisa, EL Suder… - PLoS …, 2022 - journals.plos.org
Exacerbated and persistent innate immune response marked by pro-inflammatory cytokine
expression is thought to be a major driver of chronic COVID-19 pathology. Although …

An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages

H Motamedi, MM Ari, S Dashtbin, M Fathollahi… - International …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy …